Skip to menu Skip to content Skip to footer
Professor Di Yu
Professor

Di Yu

Email: 

Overview

Background

Professor Di Yu is a Chair in Paediatric Immunotherapy, Professor of Immunology, Director of Ian Frazer Centre of Children's Immunotherapy Research, and Head of Systems and Translational T-cell Immunology Laboratory (STTIL) at the University of Queensland. He earned his PhD from the Australian National University in 2007 and postdoctoral training at the Garvan Institute of Medical Research from 2008-2010. Before joining the University of Queensland, he was a faculty member at Monash University from 2011-2016 and at the Australian National University ANU from 2017-2019. His research focuses on exploring T cell subsets and developing new therapies to regulate their functions in clinical settings, with the goal of treating autoimmune diseases and cancer. He also leads the development and application of "systems immunology" techniques to evaluate individuals' immune status.

Professor Yu has authored over 100 publications of basic and translational research in immunology, including Nature, Nature Immunology, Nature Medicine, Immunity and Science Immunology, and is a Clarivate Highly Cited Researcher. In recognising his groundbreaking research, he has been elected as a Fellow of the Australian Academy of Health and Medical Sciences (FAHMS) and honoured with accolades such as the 2023 Jacques Miller Medal from the Australian Academy of Science (AAS), the 2021 Jian Zhou Medal from the Australian Academy of Health and Medical Sciences (AAHMS), and the inaugural 2021 AbbVie New Horizon Research Award from the Australia and New Zealand Society for Immunology (ASI), among others.

Availability

Professor Di Yu is:
Available for supervision

Qualifications

  • Doctor of Philosophy, Australian National University

Research impacts

Professor Yu is the pioneer who characterised a major CD4+ helper T cell subset – follicular helper (TFH) cells, which supports and regulates B cells for antibody production, and follicular cytotoxic T (TFC) cells (also known as stem cell-like precursor exhausted T (TPEX) cells), the major CD8+ T cell subset that controls follicular infection and responds to PD-1/PD-L1 blockade immunotherapy. By revealing their novel functions and regulation, his findings have profoundly impacted vaccination design and the diagnosis and treatment of autoimmune diseases, infection and cancer.

Professor Yu has discovered critical molecular mechanisms in controlling the differentiation and function of TFH cells, which include the master transcription factor Bcl6 (Immunity) and Roquin-mediated posttranscriptional regulation (Nature). He led the research to develop a method to monitor the activity of TFH cells in humans (Immunity) and understand IL-21 as the essential TFH effector cytokine (Immunity; Journal of Experimental Medicine; Science Immunology). More recently, he identified the metabolic hormone leptin as the physiological regulator of TFH cells that influences vaccine response in healthy populations (Nature communications). Furthermore, he discovered the specific cell death pathway – ferroptosis in the regulation of TFH cell survival and demonstrated that the mitigation of TFH cell death could boost vaccine response (Nature Immunology). He also discovered TFC cells as a new subset of CD8+ T cells that controls HIV infection in TFH cells and EBV infection in B cells (Nature Immunology). TFC cells also represent the essential population in CD8+ T cells that respond to immune checkpoint therapy blocking PD-1/PD-L1.

Professor Yu has established a broad collaboration network with clinicians. He co-led the first open-label (Nature Medicine) and subsequently randomised controlled clinical trial (Annals of the Rheumatic Diseases) for low-dose IL-2 therapy in lupus, showing its mechanisms of action of regulating TFH, TH17, and TREG cells. In addition, he co-led the clinical study showing that allergen immunotherapy improves defective follicular regulatory T cells in patients with allergic rhinitis (Journal of Allergy and Clinical Immunology). He recently co-led a team to develop VEGF antibodies linked to exosomes derived from TREG cells to choroidal neovascularization (Nature Biomedical Engineering).

Works

Search Professor Di Yu’s works on UQ eSpace

122 works between 2005 and 2024

1 - 20 of 122 works

2024

Journal Article

Dysregulation in keratinocytes drives systemic lupus erythematosus onset

Tian, Jingru, Shi, Liqing, Zhang, Dingyao, Yao, Xu, Zhao, Ming, Kumari, Snehlata, Lu, Jun, Yu, Di and Lu, Qianjin (2024). Dysregulation in keratinocytes drives systemic lupus erythematosus onset. Cellular and Molecular Immunology, 1-14. doi: 10.1038/s41423-024-01240-z

Dysregulation in keratinocytes drives systemic lupus erythematosus onset

2024

Journal Article

Granzyme K+CD8+ T cells interact with fibroblasts to promote neutrophilic inflammation in nasal polyps

Guo, Cui-Lian, Wang, Chong-Shu, Wang, Zhi-Chao, Liu, Fei-Fan, Liu, Lin, Yang, Yang, Li, Xia, Guo, Bei, Lu, Ruo-Yu, Liao, Bo, Liu, Jin-Xin, Wang, Hai, Song, Jia, Yao, Yin, Zhu, Li-Ping, Yu, Di and Liu, Zheng (2024). Granzyme K+CD8+ T cells interact with fibroblasts to promote neutrophilic inflammation in nasal polyps. Nature Communications, 15 (1) 10413. doi: 10.1038/s41467-024-54685-1

Granzyme K+CD8+ T cells interact with fibroblasts to promote neutrophilic inflammation in nasal polyps

2024

Journal Article

Dimethyl fumarate ameliorates chronic graft-versus-host disease by inhibiting Tfh differentiation via Nrf2

Lyu, Fulian, Gong, Huanle, Wu, Xiaojin, Liu, Xin, Lu, Yinghao, Wei, Xiya, Liu, Chenchen, Shen, Yaoyao, Wang, Yuhang, Lei, Lei, Chen, Jia, Ma, Shoubao, Sun, Hongjian, Yu, Di, Han, JingJing, Xu, Yang and Wu, Depei (2024). Dimethyl fumarate ameliorates chronic graft-versus-host disease by inhibiting Tfh differentiation via Nrf2. Leukemia. doi: 10.1038/s41375-024-02475-5

Dimethyl fumarate ameliorates chronic graft-versus-host disease by inhibiting Tfh differentiation via Nrf2

2024

Journal Article

Interferon disrupts immune and tissue homeostasis in SLE via CXCL13

Pazhouhandeh, Mehrdad and Yu, Di (2024). Interferon disrupts immune and tissue homeostasis in SLE via CXCL13. Nature Reviews Rheumatology, 20 (12), 745-746. doi: 10.1038/s41584-024-01164-y

Interferon disrupts immune and tissue homeostasis in SLE via CXCL13

2024

Journal Article

Author Correction: Selenium–GPX4 axis protects follicular helper T cells from ferroptosis

Yao, Yin, Chen, Zhian, Zhang, Hao, Chen, Cailing, Zeng, Ming, Yunis, Joseph, Wei, Yunbo, Wan, Yanmin, Wang, Naiqi, Zhou, Mingzhe, Qiu, Chao, Zeng, Qunxiong, Ong, Hong Sheng, Wang, Hao, Makota, Fadzai Victor, Yang, Yang, Yang, Zhaohui, Wang, Nan, Deng, Jun, Shen, Chao, Xia, Yan, Yuan, Lin, Lian, Zhaoqin, Deng, Yike, Guo, Cuilian, Huang, Ao, Zhou, Pengcheng, Shi, Haibo, Zhang, Weitian ... Yu, Di (2024). Author Correction: Selenium–GPX4 axis protects follicular helper T cells from ferroptosis. Nature Immunology, 25 (9), 1764-1764. doi: 10.1038/s41590-024-01949-z

Author Correction: Selenium–GPX4 axis protects follicular helper T cells from ferroptosis

2024

Journal Article

The activity of early-life gene regulatory elements is hijacked in aging through pervasive AP-1-linked chromatin opening

Patrick, Ralph, Naval-Sanchez, Marina, Deshpande, Nikita, Huang, Yifei, Zhang, Jingyu, Chen, Xiaoli, Yang, Ying, Tiwari, Kanupriya, Esmaeili, Mohammadhossein, Tran, Minh, Mohamed, Amin R., Wang, Binxu, Xia, Di, Ma, Jun, Bayliss, Jacqueline, Wong, Kahlia, Hun, Michael L., Sun, Xuan, Cao, Benjamin, Cottle, Denny L., Catterall, Tara, Barzilai-Tutsch, Hila, Troskie, Robin-Lee, Chen, Zhian, Wise, Andrea F., Saini, Sheetal, Soe, Ye Mon, Kumari, Snehlata, Sweet, Matthew J. ... Nefzger, Christian M. (2024). The activity of early-life gene regulatory elements is hijacked in aging through pervasive AP-1-linked chromatin opening. Cell Metabolism, 36 (8), 1858-1881.e23. doi: 10.1016/j.cmet.2024.06.006

The activity of early-life gene regulatory elements is hijacked in aging through pervasive AP-1-linked chromatin opening

2024

Journal Article

International consensus guidelines for the definition, detection, and interpretation of autophagy-dependent ferroptosis

Chen, Xin, Tsvetkov, Andrey S., Shen, Han-Ming, Isidoro, Ciro, Ktistakis, Nicholas T., Linkermann, Andreas, Koopman, Werner J. H., Simon, Hans-Uwe, Galluzzi, Lorenzo, Luo, Shouqing, Xu, Daqian, Gu, Wei, Peulen, Olivier, Cai, Qian, Rubinsztein, David C., Chi, Jen-Tsan, Zhang, Donna D., Li, Changfeng, Toyokuni, Shinya, Liu, Jinbao, Roh, Jong-Lyel, Dai, Enyong, Juhasz, Gabor, Liu, Wei, Zhang, Jianhua, Yang, Minghua, Liu, Jiao, Zhu, Ling-Qiang, Zou, Weiping ... Tang, Daolin (2024). International consensus guidelines for the definition, detection, and interpretation of autophagy-dependent ferroptosis. Autophagy, 20 (6), 1213-1246. doi: 10.1080/15548627.2024.2319901

International consensus guidelines for the definition, detection, and interpretation of autophagy-dependent ferroptosis

2024

Journal Article

A Galectin-9–Driven CD11c <sup>high</sup> Decidual Macrophage Subset Suppresses Uterine Vascular Remodeling in Preeclampsia

Li, Yanhong, Sang, Yifei, Chang, Yunjian, Xu, Chunfang, Lin, Yikong, Zhang, Yao, Chiu, Philip C.N., Yeung, William S.B., Zhou, Haisheng, Dong, Ningzheng, Xu, Ling, Chen, Jiajia, Zhao, Weijie, Liu, Lu, Yu, Di, Zang, Xingxing, Ye, Jiangfeng, Yang, Jinying, Wu, Qingyu, Li, Dajin, Wu, Ligang and Du, Meirong (2024). A Galectin-9–Driven CD11c high Decidual Macrophage Subset Suppresses Uterine Vascular Remodeling in Preeclampsia. Circulation, 149 (21), 1670-1688. doi: 10.1161/circulationaha.123.064391

A Galectin-9–Driven CD11c <sup>high</sup> Decidual Macrophage Subset Suppresses Uterine Vascular Remodeling in Preeclampsia

2023

Journal Article

Inhaled SARS-CoV-2 vaccine for single-dose dry powder aerosol immunization

Ye, Tong, Jiao, Zhouguang, Li, Xin, He, Zhanlong, Li, Yanyan, Yang, Fengmei, Zhao, Xin, Wang, Youchun, Huang, Weijin, Qin, Meng, Feng, Yingmei, Qiu, Yefeng, Yang, Wenhui, Hu, Lingfei, Hu, Yaling, Zhai, Yu, Wang, Erqiang, Yu, Di, Wang, Shuang, Yue, Hua, Wang, Yishu, Wang, Hengliang, Zhu, Li, Ma, Guanghui and Wei, Wei (2023). Inhaled SARS-CoV-2 vaccine for single-dose dry powder aerosol immunization. Nature, 624 (7992), 630-638. doi: 10.1038/s41586-023-06809-8

Inhaled SARS-CoV-2 vaccine for single-dose dry powder aerosol immunization

2023

Journal Article

Systemic immunometabolism and responses to vaccines: insights from T and B cell perspectives

Nettelfield, Sam, Yu, Di and Cañete, Pablo F (2023). Systemic immunometabolism and responses to vaccines: insights from T and B cell perspectives. International Immunology, 35 (12), 571-582. doi: 10.1093/intimm/dxad021

Systemic immunometabolism and responses to vaccines: insights from T and B cell perspectives

2023

Journal Article

Low-dose IL-2 treatment rescues cognitive deficits by repairing the imbalance between Treg and Th17 cells at the middle Alzheimer’s disease stage

Yuan, Lin, Xie, Lei, Zhang, Hao, Zhang, Yu, Wei, Yunbo, Feng, Jinhong, Cui, Li, Tian, Rui, Feng, Jia, Yu, Di and Lv, Cui (2023). Low-dose IL-2 treatment rescues cognitive deficits by repairing the imbalance between Treg and Th17 cells at the middle Alzheimer’s disease stage. Journal of Neuroimmune Pharmacology, 18 (4), 674-689. doi: 10.1007/s11481-023-10090-x

Low-dose IL-2 treatment rescues cognitive deficits by repairing the imbalance between Treg and Th17 cells at the middle Alzheimer’s disease stage

2023

Journal Article

Autoimmune uveitis in Behçet's disease and Vogt‐Koyanagi‐Harada disease differ in tissue immune infiltration and T cell clonality

Kang, Hao, Sun, Hongjian, Yang, Yang, Tuong, Zewen K., Shu, Minglei, Wei, Yunbo, Zhang, Yu, Yu, Di and Tao, Yong (2023). Autoimmune uveitis in Behçet's disease and Vogt‐Koyanagi‐Harada disease differ in tissue immune infiltration and T cell clonality. Clinical and Translational Immunology, 12 (9) e1461, 1-17. doi: 10.1002/cti2.1461

Autoimmune uveitis in Behçet's disease and Vogt‐Koyanagi‐Harada disease differ in tissue immune infiltration and T cell clonality

2023

Journal Article

Severe respiratory viral infections: T-cell functions diverging from immunity to inflammation

Yunis, Joseph, Short, Kirsty R. and Yu, Di (2023). Severe respiratory viral infections: T-cell functions diverging from immunity to inflammation. Trends in Microbiology, 31 (6), 644-656. doi: 10.1016/j.tim.2022.12.008

Severe respiratory viral infections: T-cell functions diverging from immunity to inflammation

2023

Journal Article

Attenuation of renal injury by depleting cDC1 and by repurposing Flt3 inhibitor in anti-GBM disease

Chen, Titi, Cao, Qi, Wang, Ruifeng, Zheng, Guoping, Azmi, Farhana, Lee, Vincent W., Wang, Yuan Ming, Li, Hongqi, Yu, Di, Rogers, Natasha M., Alexander, Stephen I., Harris, David C.H. and Wang, Yiping (2023). Attenuation of renal injury by depleting cDC1 and by repurposing Flt3 inhibitor in anti-GBM disease. Clinical Immunology, 250 109295, 1-14. doi: 10.1016/j.clim.2023.109295

Attenuation of renal injury by depleting cDC1 and by repurposing Flt3 inhibitor in anti-GBM disease

2023

Journal Article

Heparan sulfate regulates IL-21 bioavailability and signal strength that control germinal center B cell selection and differentiation

Chen, Zhian, Cui, Yanfang, Yao, Yin, Liu, Bo, Yunis, Joseph, Gao, Xin, Wang, Naiqi, Cañete, Pablo F., Tuong, Zewen Kelvin, Sun, Hongjian, Wang, Hao, Yang, Siling, Wang, Runli, Leong, Yew Ann, Simon Davis, David, Qin, Jiahuan, Liang, Kaili, Deng, Jun, Wang, Conan K., Huang, Yen-Hua, Roco, Jonathan A., Nettelfield, Sam, Zhu, Huaming, Xu, Huajun, Yu, Zhijia, Craik, David, Liu, Zheng, Qi, Hai, Parish, Christopher and Yu, Di (2023). Heparan sulfate regulates IL-21 bioavailability and signal strength that control germinal center B cell selection and differentiation. Science immunology, 8 (80) eadd1728, 1-17. doi: 10.1126/sciimmunol.add1728

Heparan sulfate regulates IL-21 bioavailability and signal strength that control germinal center B cell selection and differentiation

2023

Journal Article

T follicular helper 17 (Tfh17) cells are superior for immunological memory maintenance

Gao, Xin, Luo, Kaiming, Wang, Diya, Wei, Yunbo, Yao, Yin, Deng, Jun, Yang, Yang, Zeng, Qunxiong, Dong, Xiaoru, Xiong, Le, Gong, Dongcheng, Lin, Lin, Pohl, Kai, Liu, Shaoling, Liu, Yu, Liu, Lu, Nguyen, Thi HO, Allen, Lilith F., Kedzierska, Katherine, Jin, Yanliang, Du, Mei-Rong, Chen, Wanping, Lu, Liangjing, Shen, Nan, Liu, Zheng, Cockburn, Ian A., Luo, Wenjing and Yu, Di (2023). T follicular helper 17 (Tfh17) cells are superior for immunological memory maintenance. eLife, 12 e82217, 1-29. doi: 10.7554/elife.82217

T follicular helper 17 (Tfh17) cells are superior for immunological memory maintenance

2023

Journal Article

Dimensionality reduction under scrutiny

Yang, Yang, Tuong, Zewen K. and Yu, Di (2023). Dimensionality reduction under scrutiny. Nature Computational Science, 3 (1), 8-9. doi: 10.1038/s43588-022-00383-1

Dimensionality reduction under scrutiny

2022

Journal Article

Dendritic cell-derived IL-27 p28 regulates T cell program in pathogenicity and alleviates acute graft-versus-host disease

Gong, Huanle, Ma, Shoubao, Chen, Jia, Yang, Bingyu, Liu, Shuangzhu, Liu, Xin, Han, Jingjing, Wu, Xiaojin, Lei, Lei, Yin, Zhinan, Sun, Hongjian, Yu, Di, Liu, Haiyan, Xu, Yang and Wu, Depei (2022). Dendritic cell-derived IL-27 p28 regulates T cell program in pathogenicity and alleviates acute graft-versus-host disease. Signal Transduction and Targeted Therapy, 7 (1) 319, 1-12. doi: 10.1038/s41392-022-01147-z

Dendritic cell-derived IL-27 p28 regulates T cell program in pathogenicity and alleviates acute graft-versus-host disease

2022

Journal Article

LncRNA IL21‐AS1 interacts with hnRNPU protein to promote IL21 overexpression and aberrant differentiation of Tfh cells in systemic lupus erythematosus

Liu, Limin, Hu, Longyuan, Long, Haojun, Zheng, Meiling, Hu, Zhi, He, Ye, Gao, Xiaofei, Du, Pei, Zhao, Hongjun, Yu, Di, Lu, Qianjin and Zhao, Ming (2022). LncRNA IL21‐AS1 interacts with hnRNPU protein to promote IL21 overexpression and aberrant differentiation of Tfh cells in systemic lupus erythematosus. Clinical and Translational Medicine, 12 (12) e1117, 1-21. doi: 10.1002/ctm2.1117

LncRNA IL21‐AS1 interacts with hnRNPU protein to promote IL21 overexpression and aberrant differentiation of Tfh cells in systemic lupus erythematosus

2022

Journal Article

Efficacy and Safety of Low-Dose Interleukin 2 for Primary Sjögren Syndrome: A Randomized Clinical Trial

He, Jing, Chen, Jiali, Miao, Miao, Zhang, Ruijun, Cheng, Gong, Wang, Yifan, Feng, Ruiling, Huang, Bo, Luan, Huijie, Jia, Yuan, Jin, Yuebo, Zhang, Xiaoying, Shao, Miao, Wang, Yu, Zhang, Xia, Li, Jing, Zhao, Xiaozhen, Wang, Han, Liu, Tian, Xiao, Xian, Zhang, Xuewu, Su, Yin, Mu, Rong, Ye, Hua, Li, Ru, Liu, Xu, Liu, Yanying, Li, Chun, Liu, Huixin ... Li, Zhanguo (2022). Efficacy and Safety of Low-Dose Interleukin 2 for Primary Sjögren Syndrome: A Randomized Clinical Trial. JAMA Network Open, 5 (11) e2241451, 1-16. doi: 10.1001/jamanetworkopen.2022.41451

Efficacy and Safety of Low-Dose Interleukin 2 for Primary Sjögren Syndrome: A Randomized Clinical Trial

Funding

Current funding

  • 2024 - 2025
    Evaluating vaccine efficacy in a preclinical humanised mouse model for paediatric sarcoma
    ANZ Sarcoma Research Grant
    Open grant
  • 2024 - 2026
    Using a novel humanized mouse model to investigate how EBV infection at different ages potentiates development of CNS demyelinating disease
    United States Congressionally Directed Medical Research Programs - Multiple Sclerosis Research Program
    Open grant
  • 2024 - 2025
    Synergising CD4 and CD8 T cell immunity in developing novel mRNA cancer vaccine
    Tour de Cure
    Open grant
  • 2024 - 2029
    Building mRNA Cancer Vaccines for Australia.
    MRFF - National Critical Infrastructure Initiative
    Open grant
  • 2024 - 2029
    Paediatric Immune Cell Atlas for Immunotherapy Innovation (PICACHIU)
    MRFF - National Critical Infrastructure Initiative
    Open grant
  • 2024 - 2026
    Deciphering interleukin-21 agonism in boosting CD8+ T cell mediated anti-tumour immunity to engineer next-generation immunotherapies
    Cure Cancer Early Career Research Grants
    Open grant
  • 2023 - 2027
    A vaccine to treat paediatric brain cancer
    The Trustee for the Robert Connor Dawes Foundation
    Open grant
  • 2023 - 2025
    Using a novel humanized mouse model to investigate how EBV infection at different ages potentiates development of CNS demyelinating disease
    National Multiple Sclerosis Society-US
    Open grant
  • 2023 - 2028
    Building the next mRNA vaccines and therapies
    MRFF - National Critical Infrastructure Initiative
    Open grant
  • 2023 - 2027
    Improving genetic diagnosis of autoimmune and autoinflammatory disease through an integrated multi-omics approach (MRFF 2022 GHFM - administered by ANU)
    The Australian National University
    Open grant
  • 2023 - 2025
    Research Donation - Children's Brain Cancer Research
    Research Donation Generic
    Open grant
  • 2023 - 2025
    Investigating the quantity and quality of T cells in paediatric solid tumours (Tour de Cure Research Grant administered by The Children's Hospital Foundation)
    The Children's Hospital Foundation
    Open grant
  • 2022 - 2026
    Targeting Follicular Helper T cells to Boost Protective Humoral Immunity
    NHMRC Investigator Grants
    Open grant
  • 2021 - 2031
    Ian Frazer Centre for Children's Immunotherapy Research
    Children's Hospital Foundation Immunotherapy Research Grants
    Open grant

Past funding

  • 2022
    Can ferroptosis be targeted to treat lupus
    ASI AbbVie New Horizons Research Award
    Open grant
  • 2021 - 2024
    Research Collaboration with Baker (Title TBC)
    Baker IDI Heart & Diabetes Institute
    Open grant
  • 2021
    Leptin as a natural regulator of TFH cell differentiation and vaccination response
    NHMRC Project Grant
    Open grant
  • 2021 - 2023
    Identification of molecular and cellular pathways predicting susceptibility or resistance to severe dengue fever (externally-led e-ASIA: Monash University)
    Monash University
    Open grant
  • 2021 - 2022
    Modelling the immune pathogenesis of COVID-19 severity for target immunotherapy
    Eureka Research Fund for Immunology and Virology
    Open grant
  • 2020 - 2022
    Follicular cytotoxic T cell differentiation and function in infection and B-cell lymphoma
    NHMRC Project Grant
    Open grant
  • 2019 - 2022
    Differentiation and function of a novel cytotoxic T-cell subset: follicular cytotoxic T cells
    Bellberry Limited - Sylvia and Charles Viertel Charitable Foundation Senior Medical Research Fellowships
    Open grant

Supervision

Availability

Professor Di Yu is:
Available for supervision

Before you email them, read our advice on how to contact a supervisor.

Supervision history

Current supervision

  • Doctor Philosophy

    Ferroptosis: a novel layer of regulation for T cell homeostasis and function

    Principal Advisor

    Other advisors: Dr Kim Bridle, Dr Joseph Yunis, Dr Zhian Chen

  • Doctor Philosophy

    An integration of multi-omics and machine learning to stratify patients with lupus nephritis for precision medicine

    Principal Advisor

    Other advisors: Dr Yang Yang

  • Doctor Philosophy

    Control of antibody selection by follicular helper T cells in vaccination and autoimmunity

    Principal Advisor

    Other advisors: Dr Zhian Chen

  • Doctor Philosophy

    Investigate T cell specificity and function in immune responses by systems immunology

    Principal Advisor

    Other advisors: Dr Kelvin Tuong, Dr Yang Yang

  • Doctor Philosophy

    Temporal tracking of T cell functional differentiation by single-cell RNA-sequencing to inform immunotherapy

    Principal Advisor

    Other advisors: Dr Pablo Canete, Dr Yang Yang

  • Doctor Philosophy

    Ferroptosis-mediated regulation of lymphocyte homeostasis and function in the liver

    Principal Advisor

    Other advisors: Professor Darrell Crawford, Dr Xiaowen Liang

  • Doctor Philosophy

    Modelling T cell functional subsets

    Principal Advisor

    Other advisors: Dr Yang Yang

  • Doctor Philosophy

    Understanding and controlling the age-stage of somatic cells

    Associate Advisor

    Other advisors: Dr Christian Nefzger

  • Doctor Philosophy

    mRNA-based T cell guided cancer vaccine to treat solid cancers.

    Associate Advisor

    Other advisors: Dr Joseph Yunis

  • Doctor Philosophy

    A Comprehensive Paediatric Immune Cell Atlas for Children's Immunotherapy Innovation

    Associate Advisor

    Other advisors: Dr Quan Nguyen, Dr Kelvin Tuong

  • Doctor Philosophy

    Urinary stem cells for diagnosis and characterisation of primary bone disorders

    Associate Advisor

    Other advisors: Professor Craig Munns

  • Doctor Philosophy

    Next-generation IL-2 mimics for immunotherapy

    Associate Advisor

    Other advisors: Professor David Craik, Dr Conan Wang

Media

Enquiries

For media enquiries about Professor Di Yu's areas of expertise, story ideas and help finding experts, contact our Media team:

communications@uq.edu.au